NightWare
Commercial- Indications
- Post-traumatic stress disorder, Nightmare disorder
Company intelligence / Profile preview
NightWare is an FDA-cleared, prescription-only digital therapeutic for adults 22+ that uses AI algorithms on the Apple Watch to detect physiological signs of nightmares and deliver vibrotactile stimulation to interrupt them without waking the patient. In a randomized controlled pivotal trial of 70 patients over 30 days, active treatment showed a greater improvement in sleep quality compared to sham control. Ongoing studies are expanding evidence generation[1][2][6].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on NightWare.